Sunovion

Jan 09, 2020

Impel NeuroPharma Announces Appointment Of Adrian Adams As Chairman Of The Board Of Directors

Jul 02, 2019

Global chronic obstructive pulmonary disease therapeutics market is expected to grow with a healthy CAGR over the forecast period from 2019-2025

May 30, 2019

Visiongain Launches Report Examining the Potential in the $38bn Respiratory Inhalers Market

Jan 31, 2019

Aquestive Therapeutics Provides Update on Licensee, Sunovion Pharmaceuticals Inc.'s Apomorphine Sublingual Film (APL-130277) New Drug Application

Jan 24, 2019

Visiongain Report Looks at Opportunities within the $47bn Asthma & COPD Market

Oct 09, 2018

Variant Pharmaceuticals Enhances Its Board of Directors with Three New Members

Jun 22, 2018

Global CNS Therapeutics Markets, 2024: Awareness Campaigns Launched by Pharma Companies to Benefit the Market

May 15, 2018

New Video Series Presented by Ronald Balkissoon Focuses on COPD

Nov 21, 2017

Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda(R) (Lurasidone Hydrochloride) in Europe

Sep 21, 2017

ProMIS Neurosciences Independent Director Anthony J. Giovinazzo Recognized with Inaugural Bloom Burton Award for Innovation in Canadian Healthcare

May 31, 2017

Schizophrenia Pipeline Therapeutics Development, Drug Profiles and Key Players Market Analysis Report Now Available at RnRMarketResearch.com